Ligand validation:5NSW

BOG: octyl beta-D-glucopyranoside

BOG is a Ligand Of Interest in 5NSW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5NSW_BOG_C_509	50%	27%	0.182	0.933	1.43	1.51	3	4	1	0	100%	1
5NSW_BOG_B_510	31%	20%	0.208	0.875	1.27	2.1	4	5	0	0	100%	0.5
5NSW_BOG_B_509	20%	23%	0.2	0.8	1.47	1.7	2	7	2	0	100%	0.5
5NSW_BOG_A_509	11%	6%	0.285	0.808	2.07	2.86	5	8	0	0	100%	1
5IUY_BOG_C_503	72%	57%	0.122	0.946	0.62	1.03	-	2	0	0	100%	1
5AZP_BOG_A_503	37%	65%	0.171	0.87	0.51	0.83	-	1	0	0	100%	1
4KRG_BOG_A_503	99%	54%	0.048	0.981	1.11	0.69	2	-	1	0	100%	1
5B5S_BOG_A_301	96%	45%	0.065	0.973	0.92	1.19	1	1	0	0	100%	1
7VL5_BOG_A_801	93%	65%	0.072	0.967	0.73	0.63	-	-	0	0	100%	1
3OEF_BOG_X_1000	87%	52%	0.071	0.944	1.24	0.65	2	-	0	0	100%	1
4PH9_BOG_A_603	86%	46%	0.087	0.957	0.9	1.16	1	1	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.